Now showing items 1-5 of 5
The nature of relapse in schizophrenia
(BioMed Cenral, 2013-02)
Background Multiple relapses characterise the course of illness in most patients with schizophrenia, yet the nature of these episodes has not been extensively researched and clinicians may not always be aware of important ...
Management of violent behaviour in acutely relapsed schizophrenics
(AOSIS Publishing, 2004-09-28)
The management of aggressive behaviour has always been a criticai issue in psychiatry. Finding measures that can be used to accurately predict the likelihood of assaultative behaviour and thus ensure timeous appropriate ...
The new-generation antipsychotics - integrating the neuropathology and pharmacology of schizophrenia
(Health & Medical Publishing Group, 1999)
Despite a well-established role for dopamine (DA) in the neuropathology of schizophrenia, and the evidence of a hyperdopaminergic state in the schizophrenic brain, many questions still remain. Typical agents acting ...
Once-monthly paliperidone palmitate in early stage schizophrenia – a retrospective, non-interventional 1-year study of patients with newly diagnosed schizophrenia
(Dove Medical Press, 2017)
Background: Long-acting antipsychotic therapy may be best suited for patients in the early stage of schizophrenia, when the most can be done before disease progression associated with poor adherence occurs. We explored the ...
Efficacy and safety profile of paliperidone palmitate injections in the management of patients with schizophrenia : an evidence-based review
(Dove Medical Press, 2018)
The course of schizophrenia is characterized by multiple relapses, incomplete remission of symptoms, enduring cognitive deficits, and social and occupational functional impairments. Nonadherence to antipsychotic medication ...